Evidence map›Paper›PMID 20077159›Full record

ReviewImmunologic research2010

Class I MHC molecules as probes of membrane patchiness: from biophysical measurements to modulation of immune responses.

Michael Edidin

Abstract readReview
In one paragraph

Review in Immunologic research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Factors contributing to the potency of CD8Trends in immunology · 2023
    Review
  3. Open MHC Class I Conformers: A Look through the Looking Glass.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Review
  6. Tracking surface glycans on live cancer cells with single-molecule sensitivity.Angewandte Chemie (International ed. in English) · 2015
    Article
  7. Article
  8. Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Michael EdidinDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA. edidin@jhu.edu
Johns Hopkins Medicine · US

Funding

CHEMISTRY AND DEVELOPMENT OF TRANSPLANTATION ANTIGENSR01AI014584 · NIAID · JOHNS HOPKINS UNIVERSITY · PI EDIDIN, MICHAEL A · 1985 to 2007
$2.8M
CHEMISTRY AND DEVELOPMENT OF TRANSPLANTATION ANTIGENSR37AI014584 · NIAID · JOHNS HOPKINS UNIVERSITY · PI EDIDIN, MICHAEL A · 1988 to 1997
–
NIAID NIH HHS AI14584NIAID NIH HHS R01 AI014584
6 · The paper itself

Abstract

Here I summarize decades of work using the biophysics of class I MHC molecules to probe the patchiness and heterogeneity of cell surfaces. This program began as a study of membranes generally. MHC molecules were a convenient probe. However, in recent years, it has become clear that the lateral distribution, clustering, of class I MHC molecules in the membrane affects their recognition by effector CTL. This offers the possibility of enhancing or reducing T-cell recognition of targets by altering the clustering of their membrane proteins.

Indexed as

AnimalsBiophysical PhenomenaCell MembraneCytotoxicity, ImmunologicDiffusionHistocompatibility Antigens Class IHumansMiceT-Lymphocytes, CytotoxicHistocompatibility Antigens Class I

Identifiers

PMID20077159
PMCPMC2892250
OpenAlexW1985780547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.